In vivo selection of phage for the optical imaging of PC-3 human prostate carcinoma in mice.
about
Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinomaAdvances in molecular imaging: targeted optical contrast agents for cancer diagnosticsPeptides as targeting probes against tumor vasculature for diagnosis and drug deliveryIn vivo fluorescence-based endoscopic detection of colon dysplasia in the mouse using a novel peptide probeNeoplasia: Where We Have Been and Where We Are GoingHigh-Throughput Approaches to the Development of Molecular Imaging Agents.Phage protein-targeted cancer nanomedicines.Techniques for molecular imaging probe designNeoplasia: the second decade.Combinatorial peptide libraries: mining for cell-binding peptides.Screening and identification of a targeting peptide to hepatocarcinoma from a phage display peptide library.Determining glioma response to radiation therapy using recombinant peptides.A generalized kinetic model for amine modification of proteins with application to phage display.Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.Potential of phage-displayed peptide library technology to identify functional targeting peptidesPhage display in molecular imaging and diagnosis of cancer.Landscape phage ligands for PC3 prostate carcinoma cellsCorruption of phage display libraries by target-unrelated clones: diagnosis and countermeasures.Molecular imaging of biological gene delivery vehicles for targeted cancer therapy: beyond viral vectors.Peptides and peptide hormones for molecular imaging and disease diagnosisPhage display and molecular imaging: expanding fields of vision in living subjects.Identification of a LNCaP-specific binding peptide using phage display.In vivo phage display selection of an ovarian cancer targeting peptide for SPECT/CT imaging.Phage display--a powerful technique for immunotherapy: 1. Introduction and potential of therapeutic applications.A novel peptide (Thx) homing to non-small cell lung cancer identified by ex vivo phage display.Selection of binding targets in parasites using phage-display and aptamer libraries in vivo and in vitro.Intravenous infusion of phage-displayed antibody library in human cancer patients: enrichment and cancer-specificity of tumor-homing phage-antibodiesProteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies.Evaluation of phage display discovered peptides as ligands for prostate-specific membrane antigen (PSMA).Development of a peptide by phage display for SPECT imaging of resistance-susceptible breast cancerNovel p16 binding peptide development for p16-overexpressing cancer cell detection using phage display.In vivo biomarkers for targeting colorectal neoplasms.Ricin detection using phage displayed single domain antibodies.Characterization of In Vivo Selected Bacteriophage for the Development of Novel Tumor-Targeting Agents with Specific Pharmacokinetics and Imaging Applications.Promiscuous tumor targeting phage proteins.Strategies for enhanced photodynamic therapy effects.Discovery of novel peptides targeting pro-atherogenic endothelium in disturbed flow regions -Targeted siRNA delivery to pro-atherogenic endothelium in vivoOptical tecnology developments in biomedicine: history, current and futureIn vivo near-infrared fluorescence imaging of cancer with nanoparticle-based probes.Optical and magnetic resonance imaging as complementary modalities in drug discovery.
P2860
Q21144653-2F18F4A1-D9A1-4EC2-9CE8-02C7A94383AAQ26829059-9EF4389B-37B3-4378-AFCF-70047D69A81CQ27024850-0F66CB3D-EB94-4850-A3B7-08EFAE7183E1Q27350293-32C0A4AC-45D5-4539-A165-7C3D8265E8E0Q28395095-3E488F93-9367-4B47-9BFD-39339FD22E99Q30275493-71A64758-F5BF-4DE6-B1D3-3CE7A5701D6CQ30403553-67A7E5EA-B1F0-4C8E-BEB7-0E36BE4A9917Q30423734-72F5F0E8-B483-4066-895E-96DD1CE23521Q30484000-19206F4C-07B2-4FA2-8881-8471B5C73C8DQ31144876-0C98DDDC-C7AE-4850-88D9-901F427C3B5FQ33290432-2A0E2E9D-ED6D-4D76-A87B-BF145C1004BBQ33382467-1CCF74D8-5464-4953-9BBE-90A2DAF467B8Q33421519-375D0E41-E3BC-412F-B4A3-8B77D3E55DD9Q33520512-802BEFAD-6CE0-49F8-865B-5975C215AB9FQ33530848-11F34E08-59E6-4A43-961A-C9A3A2FEAC50Q33532734-621FE339-66B7-4766-BA9B-4BBAC2F2D93FQ33534585-EAB29401-BAA4-4EA0-BE29-5B9A0CC919BAQ33652052-3928792A-3D14-4B22-88D4-47A080EB9D05Q33704231-53EB2A63-A5CB-4713-A125-498021F13C67Q33846924-6FBB8734-A87D-435D-87A5-20BBDBF5B833Q33849788-82319E98-E697-4EC3-8737-08567BE218AFQ33911470-D2E6D968-EE24-49E1-82E8-DF58166B3F7DQ34228815-F250D2B7-7D13-4B7D-864D-904E76B4D550Q34385892-D9FA1C6E-7812-49FB-99F4-AD1791F99DC2Q34473561-886448B4-76F9-4787-AD5C-E12121CD27BBQ34547148-B743B226-ABDB-4ECF-BCEF-CD4AFDF7C01EQ34757809-67F092C5-0E1D-44A6-8D33-DBEB37C52291Q34897576-6ECA597C-DE01-4AE6-A320-AC10BE621305Q34918072-FBB89B15-72F6-4A96-82A2-5E3BDD728E6AQ35229181-7E549B4A-DD8E-4722-B391-D4D0182A7E58Q35574209-2D4A08CB-7728-4347-A9E8-2EF1BFEF7C49Q35596304-12D8B931-2193-4B00-8589-2B6F259D227DQ35760552-0F262DA8-26C1-4E17-8953-0FF2851768E6Q36309972-868514BB-1268-48B3-B28F-3BCD2EA5D535Q36581309-6D3DC19A-3ECB-4691-9B08-550B46968125Q36945978-24E3D18C-891C-4F8E-8BDE-E77BDB21F064Q36990412-8058195D-3A76-4C26-9957-57BC814DEFC3Q37058474-947ECBF0-74C7-412B-8F21-03B0A206555BQ37766555-FEF66A88-5602-4054-AF71-5D0C7D95B0CEQ37855905-106C837A-F92E-4769-99F3-BE9EC7688A6A
P2860
In vivo selection of phage for the optical imaging of PC-3 human prostate carcinoma in mice.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
In vivo selection of phage for ...... an prostate carcinoma in mice.
@ast
In vivo selection of phage for ...... an prostate carcinoma in mice.
@en
In vivo selection of phage for ...... an prostate carcinoma in mice.
@nl
type
label
In vivo selection of phage for ...... an prostate carcinoma in mice.
@ast
In vivo selection of phage for ...... an prostate carcinoma in mice.
@en
In vivo selection of phage for ...... an prostate carcinoma in mice.
@nl
prefLabel
In vivo selection of phage for ...... an prostate carcinoma in mice.
@ast
In vivo selection of phage for ...... an prostate carcinoma in mice.
@en
In vivo selection of phage for ...... an prostate carcinoma in mice.
@nl
P2093
P2860
P356
P1433
P1476
In vivo selection of phage for ...... an prostate carcinoma in mice.
@en
P2093
Jessica R Newton
Kimberly A Kelly
Susan L Deutscher
Umar Mahmood
P2860
P304
P356
10.1593/NEO.06331
P577
2006-09-01T00:00:00Z